Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Myrtelle announced it raised $7.49 Million in an initial filing from an offering of $15 Million
PRIVATEMar 21, 2025•over 1 year ago
Amount Raised
$7.49 Million
Round Type
Venture - Series Unknown
New YorkBiotechnology
Company Information
Company
Myrtelle
Location
17 State Street
New York, New York, United States
About
Myrtelle Inc. is a patient-centered, innovation-driven gene therapy company transforming the treatment of neurological diseases. Our mission is to develop and deliver novel treatments for devastating disorders of the central nervous system, beginning with our lead program, gene therapy treatment for Canavan disease.
Don't miss Myrtelle's next move
Get an email the moment Myrtelle raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
3 contacts
Verified contactsOlga F., co-Chief Medical Officer